Treatment of Rare Systemic Autoimmune Rheumatic Diseases (SARDS): Systemic Lupus Erythematous (SLE) and Idiopathic Inflammatory Myopathies

Expert rheumatologist, Kostas N. Botsoglou, MD provides an overview of the current therapeutic landscape for Systemic Autoimmune Rheumatic Diseases (SARDs) and discusses potential treatments on the horizon.

EP. 1: An Overview of Systemic Autoimmune Rheumatic Diseases

June 7th 2021

Kostas N. Botsoglou, MD, provides an overview of systemic autoimmune rheumatic diseases (SARDs) or connective tissue diseases by discussing their overall characteristics, common comorbidities, and impact on patient quality of life.

EP. 2: Etiology of SLE and Idiopathic Inflammatory Myopathies

June 7th 2021

An expert rheumatologist shares key insights into common causes, typical presentation, and differential diagnosis of systemic lupus erythematous (SLE) and idiopathic inflammatory myopathies.

EP. 3: Goals of Therapy and Treatment Approaches for SARDs

June 14th 2021

A key opinion leader in rheumatology discusses the goals of therapy for SARDs and provides an overview of current approaches to treatment including the use of NSAIDs, corticosteroids, and immunosuppressive agents.

EP. 4: Repository Corticotropin and Immunotherapy for SARDS

June 14th 2021

An expert in rheumatic diseases considers therapeutic options for the treatment of SARDS including subcutaneous and intramuscular formulations of Repository Corticotropin Injection as well as immunosuppressive agents.

EP. 5: The Future of Individualized Therapy in SARDs

June 21st 2021

A thought leader in rheumatology, Kostas N. Botsoglou, MD, highlights the importance of individualizing therapy for SARDs and shares insight into novel treatments on the horizon that may address current unmet needs.